Clinical Trial Update: A Randomized Double Blind Controlled Trial Comparing Sugammadex and Neostigmine After Thoracic Anesthesia [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial comparing sugammadex versus neostigmine after thoracic anesthesia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Neuromuscular Blockade | Phase 4 | Status: TERMINATED